Results announcements for companies with fiscal years ending in March for the April-September 2026 period will begin in October. As share prices continue to tend to price in the outlook ahead of results, investors are watching moves to anticipate upward earnings revisions.
Results announcements for companies with fiscal years ending in March for the April-September 2026 period will begin in October. Many investors are focusing on the outlook for the fiscal year ending March 2027 rather than results for the April-September period. Share prices tend to reflect the outlook ahead of actual results.
Some investors are looking to identify companies likely to outperform their earnings forecasts in advance and generate investment returns.
In late August, a 35-year-old male office worker living in Wakayama Prefecture analyzed earnings presentation materials and other documents before purchasing shares in Rohto Pharmaceutical.